Cargando…

Biopsy strategies for endoscopic screening of pre-malignant gastric lesions

Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) were adopted to evaluate gastric risk stratification in five biopsy samples. This study aimed to evaluate the degree of gastric atrophy (GA) and intestinal metaplasia (IM) in five loc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Liu, Shan, Hu, Yue, Bao, Hai-biao, Meng, Li-na, Wang, Xiao-teng, Xu, Yi, Zhao, Jing, Lu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797776/
https://www.ncbi.nlm.nih.gov/pubmed/31624309
http://dx.doi.org/10.1038/s41598-019-51487-0
_version_ 1783459906785902592
author Zhang, Meng
Liu, Shan
Hu, Yue
Bao, Hai-biao
Meng, Li-na
Wang, Xiao-teng
Xu, Yi
Zhao, Jing
Lu, Bin
author_facet Zhang, Meng
Liu, Shan
Hu, Yue
Bao, Hai-biao
Meng, Li-na
Wang, Xiao-teng
Xu, Yi
Zhao, Jing
Lu, Bin
author_sort Zhang, Meng
collection PubMed
description Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) were adopted to evaluate gastric risk stratification in five biopsy samples. This study aimed to evaluate the degree of gastric atrophy (GA) and intestinal metaplasia (IM) in five locations to detect a more representative biopsy sample in gastric cancer (GC) screening. Our study enrolled 368 patients and 5 biopsy pieces were acquired from them. Gastric risk stratification was calculated by OLGA and OLGIM staging system. The results revealed that the IM score in the incisura angularis was higher than that in the larger and lesser curvature of corpus mucosa (p = 0.037 and p = 0.030, respectively) and the IM score in the lesser curvature of antrum mucosa was higher than that in the incisura angularis mucosa (p = 0.018). IM is more frequently observed in the angulus region than in the lesser curvature of corpus in the mild degree (p = 0.004) and mild IM lesions in the lesser curvature of antrum were more frequently observed than in the incisura angularis mucosa (p = 0.004), Four biopsy pieces protocol (larger curvature and lesser curvature of the antrum, lesser curvature of the corpus and angulus) demonstrated accurate consistency (97.83% and 98.37%, respectively) with a Kendall’s tau-b of higher than 0.990, along with low misdiagnosis rates of OLGA and OLGIM (III + IV) (9.76% and 5.00%, respectively). Three biopsy pieces protocol (lesser curvature of the antrum and corpus, angulus biopsy) in OLGA and OLGIM staging system was close to the standard protocol (five biopsy specimens) with a consistency of 94.84% and 94.29% and has a Kendall’s tau-b higher than 0.950 and diagnostic omission rates of 9.76% and 5.00%, respectively, which was exactly the same with the four biopsy pieces protocol. Furthermore, it had the second-highest Youden index (0.902 and 0.950, respectively) and area under the ROC curve (0.992 and 0.996, respectively) for the screening of high-risk GC by OLGA and OLGIM stages. Thus, we recommended the angulus and the lesser curvature of antrum as a conventional biopsy and three biopsy pieces for further GC risk screening.
format Online
Article
Text
id pubmed-6797776
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67977762019-10-25 Biopsy strategies for endoscopic screening of pre-malignant gastric lesions Zhang, Meng Liu, Shan Hu, Yue Bao, Hai-biao Meng, Li-na Wang, Xiao-teng Xu, Yi Zhao, Jing Lu, Bin Sci Rep Article Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) were adopted to evaluate gastric risk stratification in five biopsy samples. This study aimed to evaluate the degree of gastric atrophy (GA) and intestinal metaplasia (IM) in five locations to detect a more representative biopsy sample in gastric cancer (GC) screening. Our study enrolled 368 patients and 5 biopsy pieces were acquired from them. Gastric risk stratification was calculated by OLGA and OLGIM staging system. The results revealed that the IM score in the incisura angularis was higher than that in the larger and lesser curvature of corpus mucosa (p = 0.037 and p = 0.030, respectively) and the IM score in the lesser curvature of antrum mucosa was higher than that in the incisura angularis mucosa (p = 0.018). IM is more frequently observed in the angulus region than in the lesser curvature of corpus in the mild degree (p = 0.004) and mild IM lesions in the lesser curvature of antrum were more frequently observed than in the incisura angularis mucosa (p = 0.004), Four biopsy pieces protocol (larger curvature and lesser curvature of the antrum, lesser curvature of the corpus and angulus) demonstrated accurate consistency (97.83% and 98.37%, respectively) with a Kendall’s tau-b of higher than 0.990, along with low misdiagnosis rates of OLGA and OLGIM (III + IV) (9.76% and 5.00%, respectively). Three biopsy pieces protocol (lesser curvature of the antrum and corpus, angulus biopsy) in OLGA and OLGIM staging system was close to the standard protocol (five biopsy specimens) with a consistency of 94.84% and 94.29% and has a Kendall’s tau-b higher than 0.950 and diagnostic omission rates of 9.76% and 5.00%, respectively, which was exactly the same with the four biopsy pieces protocol. Furthermore, it had the second-highest Youden index (0.902 and 0.950, respectively) and area under the ROC curve (0.992 and 0.996, respectively) for the screening of high-risk GC by OLGA and OLGIM stages. Thus, we recommended the angulus and the lesser curvature of antrum as a conventional biopsy and three biopsy pieces for further GC risk screening. Nature Publishing Group UK 2019-10-17 /pmc/articles/PMC6797776/ /pubmed/31624309 http://dx.doi.org/10.1038/s41598-019-51487-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Zhang, Meng
Liu, Shan
Hu, Yue
Bao, Hai-biao
Meng, Li-na
Wang, Xiao-teng
Xu, Yi
Zhao, Jing
Lu, Bin
Biopsy strategies for endoscopic screening of pre-malignant gastric lesions
title Biopsy strategies for endoscopic screening of pre-malignant gastric lesions
title_full Biopsy strategies for endoscopic screening of pre-malignant gastric lesions
title_fullStr Biopsy strategies for endoscopic screening of pre-malignant gastric lesions
title_full_unstemmed Biopsy strategies for endoscopic screening of pre-malignant gastric lesions
title_short Biopsy strategies for endoscopic screening of pre-malignant gastric lesions
title_sort biopsy strategies for endoscopic screening of pre-malignant gastric lesions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797776/
https://www.ncbi.nlm.nih.gov/pubmed/31624309
http://dx.doi.org/10.1038/s41598-019-51487-0
work_keys_str_mv AT zhangmeng biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions
AT liushan biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions
AT huyue biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions
AT baohaibiao biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions
AT menglina biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions
AT wangxiaoteng biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions
AT xuyi biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions
AT zhaojing biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions
AT lubin biopsystrategiesforendoscopicscreeningofpremalignantgastriclesions